Literature DB >> 23880924

Use of quantitative diffusion-weighted magnetic resonance imaging to predict human papilloma virus status in patients with oropharyngeal squamous cell carcinoma.

Mitsuhiko Nakahira1, Naoko Saito, Hiroshi Yamaguchi, Kiyomi Kuba, Masashi Sugasawa.   

Abstract

Although identification of human papilloma virus (HPV) status in oropharyngeal squamous cell carcinoma (OPSCC) is essential in predicting treatment response, no imaging modality can currently determine whether a tumor is HPV-related. In this retrospective study, 26 patients with OPSCC confined to the lateral wall or the base of tongue underwent neck magnetic resonance imaging, using T1-, T2- and diffusion-weighted imaging (DWI). Apparent diffusion coefficients (ADCs) in a region of interest covering the largest available primary tumor area of OPSCC on a single slice of the ADC map were calculated using two b values (0 and 1,000 s/mm(2)). Mean and minimum ADCs were compared with HPV status, using p16 immunohistochemistry as a surrogate marker for HPV infection. Mean and minimum ADCs for HPV(+) OPSCC were significantly lower than those for HPV(-) OPSCC. A cut-off value of mean ADC for HPV(+) OPSCC of 1.027 × 10(-3) mm(2)/s yielded sensitivity and specificity of 83.33 and 78.57%, respectively. In conclusion, the present study indicates that ADC could be used to predict HPV status in patients with OPSCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23880924     DOI: 10.1007/s00405-013-2641-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  39 in total

Review 1.  Diffusion-weighted magnetic resonance imaging and its application to cancer.

Authors:  Elizabeth M Charles-Edwards; Nandita M deSouza
Journal:  Cancer Imaging       Date:  2006-09-13       Impact factor: 3.909

2.  p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters.

Authors:  C A Fischer; M Kampmann; I Zlobec; E Green; L Tornillo; A Lugli; M Wolfensberger; L M Terracciano
Journal:  Ann Oncol       Date:  2010-04-27       Impact factor: 32.976

3.  Posttreatment CT and MR imaging in head and neck cancer: what the radiologist needs to know.

Authors:  Naoko Saito; Rohini N Nadgir; Mitsuhiko Nakahira; Masahiro Takahashi; Akira Uchino; Fumiko Kimura; Minh Tam Truong; Osamu Sakai
Journal:  Radiographics       Date:  2012 Sep-Oct       Impact factor: 5.333

4.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

5.  Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging.

Authors:  J Wang; S Takashima; F Takayama; S Kawakami; A Saito; T Matsushita; M Momose; T Ishiyama
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

Review 6.  HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients.

Authors:  Max Robinson; Andrew Schache; Philip Sloan; Selvam Thavaraj
Journal:  Head Neck Pathol       Date:  2012-07-03

7.  Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.

Authors:  Sungheon Kim; Laurie Loevner; Harry Quon; Eric Sherman; Gregory Weinstein; Alex Kilger; Harish Poptani
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

8.  Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.

Authors:  Richard C Jordan; Mark W Lingen; Bayardo Perez-Ordonez; Xin He; Robert Pickard; Michael Koluder; Bo Jiang; Paul Wakely; Weihong Xiao; Maura L Gillison
Journal:  Am J Surg Pathol       Date:  2012-07       Impact factor: 6.394

Review 9.  Diffusion-weighted MRI in the body: applications and challenges in oncology.

Authors:  Dow-Mu Koh; David J Collins
Journal:  AJR Am J Roentgenol       Date:  2007-06       Impact factor: 3.959

Review 10.  Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis.

Authors:  Camille C R Ragin; Emanuela Taioli
Journal:  Int J Cancer       Date:  2007-10-15       Impact factor: 7.396

View more
  16 in total

1.  Quantitative diffusion-weighted MRI parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.

Authors:  C S Schouten; P de Graaf; E Bloemena; B I Witte; B J M Braakhuis; R H Brakenhoff; C R Leemans; J A Castelijns; R de Bree
Journal:  AJNR Am J Neuroradiol       Date:  2015-02-26       Impact factor: 3.825

2.  Adaptive Boost Target Definition in High-Risk Head and Neck Cancer Based on Multi-imaging Risk Biomarkers.

Authors:  Feifei Teng; Madhava Aryal; Jae Lee; Choonik Lee; Xioajin Shen; Peter G Hawkins; Michelle Mierzwa; Avraham Eisbruch; Yue Cao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-12-21       Impact factor: 7.038

3.  Apparent Diffusion Coefficient Histograms of Human Papillomavirus-Positive and Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma: Assessment of Tumor Heterogeneity and Comparison with Histopathology.

Authors:  T de Perrot; V Lenoir; M Domingo Ayllón; N Dulguerov; M Pusztaszeri; M Becker
Journal:  AJNR Am J Neuroradiol       Date:  2017-09-14       Impact factor: 3.825

4.  Discrimination of HPV status using CT texture analysis: tumour heterogeneity in oropharyngeal squamous cell carcinomas.

Authors:  Ji Young Lee; Miran Han; Kap Seon Kim; Su-Jin Shin; Jin Wook Choi; Eun Ju Ha
Journal:  Neuroradiology       Date:  2019-10-22       Impact factor: 2.804

5.  Diffusion-Weighted Imaging of Nasopharyngeal Carcinoma: Can Pretreatment DWI Predict Local Failure Based on Long-Term Outcome?

Authors:  B K H Law; A D King; K S Bhatia; A T Ahuja; M K M Kam; B B Ma; Q Y Ai; F K F Mo; J Yuan; D K W Yeung
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-05       Impact factor: 3.825

6.  Quantitative diffusion magnetic resonance imaging for prediction of human papillomavirus status in head and neck squamous-cell carcinoma: A systematic review and meta-analysis.

Authors:  Seyedmehdi Payabvash; Aimee Chan; Pejman Jabehdar Maralani; Ajay Malhotra
Journal:  Neuroradiol J       Date:  2019-05-14

Review 7.  Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology.

Authors:  Travis C Salzillo; Nicolette Taku; Kareem A Wahid; Brigid A McDonald; Jarey Wang; Lisanne V van Dijk; Jillian M Rigert; Abdallah S R Mohamed; Jihong Wang; Stephen Y Lai; Clifton D Fuller
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

8.  Diffusion-Weighted Imaging to Assess HPV-Positive versus HPV-Negative Oropharyngeal Squamous Cell Carcinoma: The Importance of b-Values.

Authors:  V Lenoir; B M A Delattre; Y M'RaD; C De Vito; T de Perrot; M Becker
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-26       Impact factor: 4.966

9.  Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation.

Authors:  M Ravanelli; A Grammatica; M Maddalo; M Ramanzin; G M Agazzi; E Tononcelli; S Battocchio; P Bossi; M Vezzoli; R Maroldi; D Farina
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-30       Impact factor: 3.825

10.  The impact of radiomics for human papillomavirus status prediction in oropharyngeal cancer: systematic review and radiomics quality score assessment.

Authors:  Gaia Spadarella; Lorenzo Ugga; Giuseppina Calareso; Rossella Villa; Serena D'Aniello; Renato Cuocolo
Journal:  Neuroradiology       Date:  2022-04-23       Impact factor: 2.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.